CnogaCare
Developing noninvasive medical devices.
| Date | Investors | Amount | Round |
|---|---|---|---|
$50.0m | Early VC | ||
| Total Funding | 000k | ||
Related Content
Cnoga Medical Ltd., operating as CnogaCare, is a privately held medical device company established in 2004 by Dr. Yosef Segman, who currently serves as the Chairman and Chief Technology Officer. Dr. Segman, an electrical engineer with a Ph.D. from the Technion, has a background in developing algorithms for image processing, machine learning, and signal processing, which forms the technological foundation of the company. The company is headquartered in Or Yehuda, Israel, with a presence in Shanghai, China, and São Paulo, Brazil.
CnogaCare focuses on the development and manufacturing of non-invasive medical monitoring devices, aiming to shift the paradigm of patient care from reactive to proactive. The company has developed a proprietary technology that utilizes a real-time color image sensor and unique algorithms to measure a wide array of physiological parameters without the need for blood samples. This technology analyzes the color changes in a patient's finger to derive critical health data.
The company's product portfolio includes devices like the CoG™, TensorTip™, and VMLife™. These devices are designed for both personal and professional use, serving individuals managing chronic conditions at home as well as healthcare providers in clinical settings. The flagship product line offers non-invasive monitoring of up to 15 biomarkers, such as blood glucose, hemoglobin, hematocrit, blood pressure, and pulse. These devices connect to a secure cloud-based platform, allowing for continuous monitoring and data sharing with caregivers and medical professionals, thereby facilitating remote patient management and telehealth services.
CnogaCare's business model appears to be centered on the sale of these medical devices and potentially recurring revenue through its cloud-based data management platform. The company targets the digital health and remote patient monitoring markets, addressing the growing need for accessible and pain-free diagnostics for chronic diseases like diabetes and hypertension. CnogaCare has secured regulatory approvals, including the CE Mark in Europe, for its non-invasive glucometer and other devices, enabling its commercialization in numerous countries.
Keywords: non-invasive monitoring, medical devices, digital health, remote patient monitoring, telehealth, chronic disease management, biomarker tracking, pain-free diagnostics, medical technology, personal health